Drug Profile
Pneumococcal vaccine conjugate 11-valent - GlaxoSmithKline
Alternative Names: 11-Pn-CV; 11Pn-PD; GSK 513026; Pneumococcal 11-valent vaccine conjugate - GlaxoSmithKlineLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class Pneumococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pneumococcal infections
Most Recent Events
- 31 Dec 2011 Discontinued during 2011 - Phase-III for Pneumococcal infections (in children, prevention) in Slovakia (IM)
- 31 Dec 2011 Discontinued during 2011 - Phase-III for Pneumococcal infections (in infants, prevention) in Czech Republic and Slovakia (IM)
- 31 Dec 2011 Discontinued - Phase-II for Pneumococcal infections (prevention in infants) in Germany (IM)